Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor
The present invention relates to a chimeric antigen receptor (CAR) capable of targeting cells expressing p95HER2. The invention also relates to a single-chain variable fragment (ScFv), an antigen binding domain, and an antibody or an antibody fragment thereof capable of binding to a p95HER2 antigen....
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ROM ¨ ¢ N ALONSO, MARCOS KLEIN CHRISTIAN FAJARDO CALDERON, CARLOS ALBERTO ARRIBAS L ¨U PEZ, JES ¨ 2 S RIUS RUIZ IGNACIO MOESSNER EKKEHARD GROS VIDAL, ALBERTO |
| description | The present invention relates to a chimeric antigen receptor (CAR) capable of targeting cells expressing p95HER2. The invention also relates to a single-chain variable fragment (ScFv), an antigen binding domain, and an antibody or an antibody fragment thereof capable of binding to a p95HER2 antigen. The invention also relates to a cancer diagnosis method and a pharmaceutical composition for use in a method for preventing or treating cancer, the pharmaceutical composition comprising the CAR and/or the antigen binding domain or the antibody of the invention.
本发明涉及一种能够靶向表达p95HER2的细胞的嵌合抗原受体(CAR)。本发明还涉及一种单链可变片段(ScFv)、抗原结合结构域以及能够与p95HER2抗原结合的抗体或其抗体片段。本发明还涉及一种癌症诊断方法和在预防或治疗癌症的方法中的使用的药物组合物，所述药物组合物包括本发明的所述CAR和/或所述抗原结合结构域或所述抗体。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115776910A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115776910A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115776910A3</originalsourceid><addsrcrecordid>eNqNjLEKwjAQQLM4iPoP5wcIRqmlo4RKJxFxL-G82IOaHMmB-Pd2cBWcHjweb27QDfykzAg-Kj8oQiYk0ZThxTpAEUIOjKxvCJO8NFXXXndTfQcvMjJ65RQhBcBfp6WZBT8WWn25MOtTe3PdhiT1VMQjRdLena2t6vrQ2O1x_0_zAUHLPdo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor</title><source>esp@cenet</source><creator>ROM ¨ ¢ N ALONSO, MARCOS ; KLEIN CHRISTIAN ; FAJARDO CALDERON, CARLOS ALBERTO ; ARRIBAS L ¨U PEZ, JES ¨ 2 S ; RIUS RUIZ IGNACIO ; MOESSNER EKKEHARD ; GROS VIDAL, ALBERTO</creator><creatorcontrib>ROM ¨ ¢ N ALONSO, MARCOS ; KLEIN CHRISTIAN ; FAJARDO CALDERON, CARLOS ALBERTO ; ARRIBAS L ¨U PEZ, JES ¨ 2 S ; RIUS RUIZ IGNACIO ; MOESSNER EKKEHARD ; GROS VIDAL, ALBERTO</creatorcontrib><description>The present invention relates to a chimeric antigen receptor (CAR) capable of targeting cells expressing p95HER2. The invention also relates to a single-chain variable fragment (ScFv), an antigen binding domain, and an antibody or an antibody fragment thereof capable of binding to a p95HER2 antigen. The invention also relates to a cancer diagnosis method and a pharmaceutical composition for use in a method for preventing or treating cancer, the pharmaceutical composition comprising the CAR and/or the antigen binding domain or the antibody of the invention.
本发明涉及一种能够靶向表达p95HER2的细胞的嵌合抗原受体(CAR)。本发明还涉及一种单链可变片段(ScFv)、抗原结合结构域以及能够与p95HER2抗原结合的抗体或其抗体片段。本发明还涉及一种癌症诊断方法和在预防或治疗癌症的方法中的使用的药物组合物，所述药物组合物包括本发明的所述CAR和/或所述抗原结合结构域或所述抗体。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230310&DB=EPODOC&CC=CN&NR=115776910A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230310&DB=EPODOC&CC=CN&NR=115776910A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROM ¨ ¢ N ALONSO, MARCOS</creatorcontrib><creatorcontrib>KLEIN CHRISTIAN</creatorcontrib><creatorcontrib>FAJARDO CALDERON, CARLOS ALBERTO</creatorcontrib><creatorcontrib>ARRIBAS L ¨U PEZ, JES ¨ 2 S</creatorcontrib><creatorcontrib>RIUS RUIZ IGNACIO</creatorcontrib><creatorcontrib>MOESSNER EKKEHARD</creatorcontrib><creatorcontrib>GROS VIDAL, ALBERTO</creatorcontrib><title>Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor</title><description>The present invention relates to a chimeric antigen receptor (CAR) capable of targeting cells expressing p95HER2. The invention also relates to a single-chain variable fragment (ScFv), an antigen binding domain, and an antibody or an antibody fragment thereof capable of binding to a p95HER2 antigen. The invention also relates to a cancer diagnosis method and a pharmaceutical composition for use in a method for preventing or treating cancer, the pharmaceutical composition comprising the CAR and/or the antigen binding domain or the antibody of the invention.
本发明涉及一种能够靶向表达p95HER2的细胞的嵌合抗原受体(CAR)。本发明还涉及一种单链可变片段(ScFv)、抗原结合结构域以及能够与p95HER2抗原结合的抗体或其抗体片段。本发明还涉及一种癌症诊断方法和在预防或治疗癌症的方法中的使用的药物组合物，所述药物组合物包括本发明的所述CAR和/或所述抗原结合结构域或所述抗体。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAQQLM4iPoP5wcIRqmlo4RKJxFxL-G82IOaHMmB-Pd2cBWcHjweb27QDfykzAg-Kj8oQiYk0ZThxTpAEUIOjKxvCJO8NFXXXndTfQcvMjJ65RQhBcBfp6WZBT8WWn25MOtTe3PdhiT1VMQjRdLena2t6vrQ2O1x_0_zAUHLPdo</recordid><startdate>20230310</startdate><enddate>20230310</enddate><creator>ROM ¨ ¢ N ALONSO, MARCOS</creator><creator>KLEIN CHRISTIAN</creator><creator>FAJARDO CALDERON, CARLOS ALBERTO</creator><creator>ARRIBAS L ¨U PEZ, JES ¨ 2 S</creator><creator>RIUS RUIZ IGNACIO</creator><creator>MOESSNER EKKEHARD</creator><creator>GROS VIDAL, ALBERTO</creator><scope>EVB</scope></search><sort><creationdate>20230310</creationdate><title>Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor</title><author>ROM ¨ ¢ N ALONSO, MARCOS ; KLEIN CHRISTIAN ; FAJARDO CALDERON, CARLOS ALBERTO ; ARRIBAS L ¨U PEZ, JES ¨ 2 S ; RIUS RUIZ IGNACIO ; MOESSNER EKKEHARD ; GROS VIDAL, ALBERTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115776910A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ROM ¨ ¢ N ALONSO, MARCOS</creatorcontrib><creatorcontrib>KLEIN CHRISTIAN</creatorcontrib><creatorcontrib>FAJARDO CALDERON, CARLOS ALBERTO</creatorcontrib><creatorcontrib>ARRIBAS L ¨U PEZ, JES ¨ 2 S</creatorcontrib><creatorcontrib>RIUS RUIZ IGNACIO</creatorcontrib><creatorcontrib>MOESSNER EKKEHARD</creatorcontrib><creatorcontrib>GROS VIDAL, ALBERTO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROM ¨ ¢ N ALONSO, MARCOS</au><au>KLEIN CHRISTIAN</au><au>FAJARDO CALDERON, CARLOS ALBERTO</au><au>ARRIBAS L ¨U PEZ, JES ¨ 2 S</au><au>RIUS RUIZ IGNACIO</au><au>MOESSNER EKKEHARD</au><au>GROS VIDAL, ALBERTO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor</title><date>2023-03-10</date><risdate>2023</risdate><abstract>The present invention relates to a chimeric antigen receptor (CAR) capable of targeting cells expressing p95HER2. The invention also relates to a single-chain variable fragment (ScFv), an antigen binding domain, and an antibody or an antibody fragment thereof capable of binding to a p95HER2 antigen. The invention also relates to a cancer diagnosis method and a pharmaceutical composition for use in a method for preventing or treating cancer, the pharmaceutical composition comprising the CAR and/or the antigen binding domain or the antibody of the invention.
本发明涉及一种能够靶向表达p95HER2的细胞的嵌合抗原受体(CAR)。本发明还涉及一种单链可变片段(ScFv)、抗原结合结构域以及能够与p95HER2抗原结合的抗体或其抗体片段。本发明还涉及一种癌症诊断方法和在预防或治疗癌症的方法中的使用的药物组合物，所述药物组合物包括本发明的所述CAR和/或所述抗原结合结构域或所述抗体。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN115776910A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Chimeric antigen receptor with specificity for P95HER2 and application of chimeric antigen receptor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T22%3A57%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROM%20%C2%A8%20%C2%A2%20N%20ALONSO,%20MARCOS&rft.date=2023-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115776910A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |